Qube Research & Technologies (QRT)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-112	Closed	-$8K	–	2855
2021 Q4	$8K	Buy	112 +15	+15%	+$1.09K	﹤0.01%	2420
2021 Q3	$7K	Sell	97 -82	-46%	-$6.25K	﹤0.01%	2060
2021 Q2	$14K	Buy	+179	New	+$13.3K	﹤0.01%	2120

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PBE Position: Q1 2022 in Review

Qube Research & Technologies (QRT) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2022, closing a stake of 112 shares — an estimated $8K sold.

Qube Research & Technologies (QRT) first reported a position in PBE in Q2 2021 and held it in 3 quarters. The position peaked at $14K in Q2 2021. 89 funds tracked by Wall St. Rank hold PBE as of Q1 2022.

Qube Research & Technologies (QRT) reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2022 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 112 Invesco Biotechnology & Genome ETF shares in Q1 2022, an estimated $8K.
Qube Research & Technologies (QRT) first reported a position in Invesco Biotechnology & Genome ETF in Q2 2021 and held it in 3 quarters.
Qube Research & Technologies (QRT)'s Invesco Biotechnology & Genome ETF position peaked at $14K in Q2 2021.
89 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2022, filed 9 May 2022.